DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
The CDK12-BRCA1 signaling axis mediates dinaciclib-associated radiosensitivity through p53-mediated cellular senescence
Pan-cyclin-dependent-kinase (CDK) inhibitors are a new class of targeted therapies that can act on multiple CDKs, with dinaciclib being one of the most promising compounds. Although used as a monotherapy, an interesting approach could be to combine it with radiotherapy. Here, we show that dinaciclib increases radiosensitivity in some experimental models of lung and colon cancer (A549 or HCT 116) but not in others (H1299 or HT-29). Dinaciclib did not alter serine-protein kinase ATM signalling or cell cycle profiling after ionising-radiation exposure, which have been described for other CDK inhibitors. Interestingly, in terms of apoptosis, although the combination renders a clear increase, no potentiation of the ionising-radiation-induced apoptosis was observed. Mechanistically, inhibition of CDK12 by dinaciclib diminishes BRCA1 expression, which decreases homologous recombination (HR) and probably promotes the nonhomologous end joining repair process (NHEJ), which ultimately promotes the induction of ionising-radiation-associated cellular senescence in a TP53-dependent manner, explaining the lack of effect observed in some experimental models. In conclusion, our report proposes a molecular mechanism, based on the signalling axis CDK12-BRCA1, involved in this newly identified therapeutic effect of dinaciclib, although other players implicated in HR should not be discarded. In addition, our data provide a rationale for more selective and personalised chemo/radiotherapy treatment according to the genetic background of the tumour., We appreciate the technical assistance of SIB at IB, core facilities of IIB and the staff from the Radiotherapy Unit at the General Universitary Hospital of Albacete This work has been supported by grant PID2021-122222OB-I00 and PID2021-122600OB-I00 funded by MCIN/AEI/10.13039/501100011033/ and by Europena Regional Development Fund (FEDER) A way to make Europe and grant to RS-P and IP. S2022/BMD-7393 funded by Regional Government of Madrid to IP. PH lab is funded by grant PID2022-136791NB-I00 from MICIU/AEI/10.13039/501100011033/FEDER/UE. RS-P is also funded by UCLM with grant 2022-GRIN-34150 and by Agencia de Investigación e Innovación, Junta de Comunidades de Castilla-La Mancha grant SBPLY/23/180225/000007. FJC is funded by contracts for postdoctoral researchers for scientific excellence in the development of the Plan Propio I + D + i, co-financed by the European Social Fund Plus (ESF+). NGF is funded by ‘Investigo Programme’, for hiring young job seekers to carry out research and innovation initiatives, within the framework of the Recovery, Transformation and Resilience Plan – financed by the European Union – Next Generation EU, called by Order 190/2021, of 22 December, of the Regional Ministry of Economy, Business and Employment of the Regional Government of Castilla-La Mancha. JJ-S is funded by ‘Contrato predoctoral para la formación de personal investigador en el marco del plan propio de I + D + I UCLM 2020-PREDUCLM-15144’, co-financed by the European Social Fund Plus (ESF+). AD-C is funded with FPU fellowships from the Ministerio de Educación, Formación Profesional y Deportes (Lpb23). We are grateful for the funds contributed by Fundacion Leticia Castillejo and by the participants in the crowdfunding project ‘Irradiando Esperanza’, in particular to: Taller Solidario Árbol De La Vida (Las Pedroñeras), Asociación Comarcal Contra El Cáncer De Motilla Del Palancar, asociación Jareña Contra el Cancer Junta local contra el cáncer de Casimarro, and ACEPAIN., Peer reviewed
Proyecto:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2021-122222OB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2021-122600OB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2022-136791NB-I00
DOI: http://hdl.handle.net/10261/387216, https://api.elsevier.com/content/abstract/scopus_id/85211128885
HANDLE: http://hdl.handle.net/10261/387216, https://api.elsevier.com/content/abstract/scopus_id/85211128885